
Audientes
0,01
DKK
-5,77 %
AUDNTS
Spotlight Stock Market
Medical Equipment & Services
Health Care
Audientes A/S er en dansk høresundhedsvirksomhed med speciale i smarte, selvtilpassede og prisbillige høreapparater og avancerede hearables. Audientes' unikke høreapparatløsning, Ven™ by Audientes, kan købes på det indiske og nepalesiske marked og vil blive introduceret på andre markeder i de kommende år. Companion by Audientes er et avanceret høreteknisk hjælpemiddel (advanced hearable), et forbrugerelektronikprodukt, der er kommercielt tilgængeligt i Europa og senere i 2024 i Japan, Kina og andre markeder. Audientes' mission er at gøre høreapparater og høreteknisk hjælpemidler af høj kvalitet ttilgængelige for alle, der har brug for dem globalt. Audientes er noteret på Spotlight Stock Market Denmark (AUDNTS) og har hovedkontor i København, Danmark med et datterselskab i Hyderabad, Indien. For yderligere oplysninger henvises til virksomhedens hjemmesider, www.audientes.com, www.audientes.eu eller www.audientes.in.
Læs mereFinanskalender
Delårsrapport Q2'25
Delårsrapport Q3'25
Årsrapport '25

Audientes A/S: Q1 2025 Financial Report

Audientes – Q1 2025 results presentation
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Audientes to launch Companion on Amazon across 10 European markets in partnership with RMXdirect
Audientes forms strategic partnership with Rocket Revenue to strengthen sales and drive online growth for the company and its resellers
Audientes A/S: Outcome of Annual General Meeting 2025
Audientes A/S: Market Price Correction in VWAP Used for Partial Loan Conversion by Selandia Alpha Invest
Audientes A/S: Selandia Alpha Invest Partially Convert Loan to Shares at Market Price, Triggering Flagging Notification
Audientes A/S expands into hearing protection and defence - a natural next step for its platform
Audientes Partners with Explainer's Videobuddy to Supercharge Video Marketing and Support Retail Growth.
Audientes A/S: Notice of Annual General Meeting 2025
Audientes A/S: Annual Report 2024

Dagens aktienyheder 01/04: Agillic, Audientes, Ascelia Pharma og Pharma Equity Group
Correction: Audientes A/S secures financing to support global operations through directed issue and debt conversion of DKK 1.2 Million
Audientes A/S secures financing to support global operations through directed issue and debt conversion of DKK 1.2 Million
Audientes A/S: Convertible Loan Lenders Partially Convert Loans to Shares at Market Price, Triggering Flagging Notification

Audientes – Q4 2024 / End of year results
